A study presented at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago found an antibody-based experimental therapy is lengthening the life-span of patients suffering from ...
A Ministry of Health, Labor and Welfare research team has announced the five-year survival rates for people diagnosed with ...
AstraZeneca is preparing to talk to the FDA about a potential new use of its immunotherapy Imfinzi after a pivotal study in early-stage stomach cancer met its main goal. When added to a chemotherapy ...
MedPage Today on MSN
FDA OKs Perioperative Immunotherapy for Stomach Cancer
The FDA approved perioperative durvalumab (Imfinzi) in combination with a multidrug chemotherapy regimen for resectable ...
Japan reported an age-standardised incidence rate of 27.6 per 100,000 people in 2022, with 126,000 new cases diagnosed each ...
Early-stage gastric cancer can be assessed more accurately using a new liquid biopsy tool that predicts lymph node metastasis ...
The equity gap has swelled since four decades ago, according to analysis of data from almost one million cancer patients.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback